Laboratorios Farmaceuticos Forecast, price target & analysts
Laboratorios Farmaceuticos Target price 2026 - Analyst rating & recommendation
Laboratorios Farmaceuticos Classifications & Recommendation
Laboratorios Farmaceuticos Price Target
| Target Price | €77.01 |
| Price | €59.35 |
| Potential |
29.76%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Laboratorios Farmaceuticos 2027 .
The average Laboratorios Farmaceuticos target price is €77.01.
This is
29.76%
register free of charge
€89.88
51.44%
register free of charge
€64.84
9.25%
register free of charge
|
|
| A rating was issued by 17 analysts: 10 Analysts recommend Laboratorios Farmaceuticos to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Laboratorios Farmaceuticos stock has an average upside potential 2027 of
29.76%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million € | 743.48 | 788.66 |
| 2.65% | 6.08% | |
| EBITDA Margin | 29.07% | 27.43% |
| 6.98% | 5.65% | |
| Net Margin | 18.89% | 17.04% |
| 5.40% | 9.79% |
12 Analysts have issued a sales forecast Laboratorios Farmaceuticos 2026 . The average Laboratorios Farmaceuticos sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Laboratorios Farmaceuticos EBITDA forecast 2026. The average Laboratorios Farmaceuticos EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Laboratorios Farmaceuticos Analysts have issued a net profit forecast 2026. The average Laboratorios Farmaceuticos net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 2.75 | 2.63 |
| 3.00% | 4.36% | |
| P/E | 22.59 | |
| EV/Sales | 3.82 |
12 Analysts have issued a Laboratorios Farmaceuticos forecast for earnings per share. The average Laboratorios Farmaceuticos EPS is
This results in the following potential growth metrics and future valuations:
Laboratorios Farmaceuticos...
Current Laboratorios Farmaceuticos Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ALANTRA EQUITIES |
Locked
➜
Locked
|
Locked | Aug 24 2026 |
| BESTINVER SECURITIES |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| ANALISIS BANCO SABADELL |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| BANCO SANTANDER |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 23 2026 |
| CAIXABANK BPI |
Locked
➜
Locked
|
Locked | Jul 22 2026 |
| BNP PARIBAS |
Locked
➜
Locked
|
Locked | Jul 22 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
ALANTRA EQUITIES:
Locked
➜
Locked
|
Aug 24 2026 |
|
Locked
BESTINVER SECURITIES:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
ANALISIS BANCO SABADELL:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
BANCO SANTANDER:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 23 2026 |
|
Locked
CAIXABANK BPI:
Locked
➜
Locked
|
Jul 22 2026 |
|
Locked
BNP PARIBAS:
Locked
➜
Locked
|
Jul 22 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
